CD8+ T cell suppressor factors and the control of infection, replication and transcription of human immunodeficiency virus
- PMID: 11266085
CD8+ T cell suppressor factors and the control of infection, replication and transcription of human immunodeficiency virus
Abstract
CD8+ T cells have been shown to produce factors which modulate HIV-1 replication in both T cells and monocytic cells. Examination of the literature reveals that this modulation may occur by the production of beta-chemokines which block viral entry. However, another CD8+ T cell-derived factor(s) targets the replication of HIV-1 at the level of transcription. CD8+ T cell factors strongly suppress replication at the level of transcription in T cells and T cell lines, the factors enhance both replication and transcription in cells of the monocyte/macrophage lineage. The enhancement of transcription and replication, which is pertussis toxin sensitive is induced by increased production of TNF-alpha by the target cells. Thus, CD8+ T cells produce factors which mediate effects on transcription and replication of HIV-1 in a cell type-dependent manner. In this review a summary of the effects of chemokines and CD8-derived factors on HIV-1 transcription and replication is presented focusing on the cellular pathways which may mediate their effects on HIV transcription and replication in different cell types. The virus-host cell interactions that participate in the persistent replication of HIV in macrophages and the suppression of these functions in T cells require definition. The identification of CD8+ T cell factors which exert these controls on HIV-1 may lead to promising new therapies for HIV infection.
Similar articles
-
CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor.J Infect Dis. 1999 May;179 Suppl 3:S485-8. doi: 10.1086/314808. J Infect Dis. 1999. PMID: 10099125 Review.
-
Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.J Virol. 2007 Sep;81(18):9693-706. doi: 10.1128/JVI.00492-07. Epub 2007 Jul 3. J Virol. 2007. PMID: 17609262 Free PMC article. Clinical Trial.
-
H. saimiri tyrosine-kinase interacting protein inhibits Tat function: a prototypic strategy for restricting HIV-1-induced cytopathic effects in immune cells.Virology. 2006 Sep 1;352(2):253-67. doi: 10.1016/j.virol.2006.04.016. Epub 2006 Jun 15. Virology. 2006. PMID: 16780912
-
Influence of prothymosin-alpha on HIV-1 target cells.Ann N Y Acad Sci. 2007 Sep;1112:269-85. doi: 10.1196/annals.1415.043. Epub 2007 Jun 28. Ann N Y Acad Sci. 2007. PMID: 17600282 Review.
-
Antigen-specific beta-chemokine production and CD8 T-cell noncytotoxic antiviral activity in HIV-2-infected individuals.Scand J Immunol. 2005 Jan;61(1):63-71. doi: 10.1111/j.0300-9475.2005.01530.x. Scand J Immunol. 2005. PMID: 15644124
Cited by
-
Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages.J Virol. 2006 Sep;80(18):9200-6. doi: 10.1128/JVI.00589-06. J Virol. 2006. PMID: 16940531 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials